NASDAQ:BBI
Delisted
Brickell Biotech Inc. Stock News
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit
04:38pm, Monday, 18'th Apr 2022 PennyStocks
Popular Reddit penny stocks to watch under $1.
The post Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit
12:38pm, Monday, 18'th Apr 2022
Popular Reddit penny stocks to watch under $1. The post Best Penny Stocks Today?
Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April
05:37pm, Thursday, 14'th Apr 2022 PennyStocks
Penny stocks under $1 to watch right now.
The post Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April
01:37pm, Thursday, 14'th Apr 2022
Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now?
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q4 2021 Results - Earnings Call Transcript
06:39pm, Tuesday, 15'th Mar 2022 Seeking AlphaBrickell Biotech, Inc. 2021 Q4 - Results - Earnings Call Presentation
04:13pm, Tuesday, 15'th Mar 2022 Seeking AlphaBrickell Biotech, Inc. (BBI) CEO Robert Brown on Q4 2021 Results - Earnings Call Transcript
02:39pm, Tuesday, 15'th Mar 2022
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q4 2021 Results - Earnings Call Transcript
Brickell (BBI) Reports Q4 Loss, Misses Revenue Estimates
12:45pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Brickell (BBI) delivered earnings and revenue surprises of 33.33% and 49.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
11:46am, Tuesday, 15'th Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Anaptys Discontinues Phase 2 Study Of Imsidolimab In Acne
Anaptys Bio, Inc. (NASDAQ: ANAB) said the Ph
Brickell Biotech GAAP EPS of -$0.06 beats by $0.03, revenue of $0.1M misses by $0.05M (NASDAQ:BBI)
11:33am, Tuesday, 15'th Mar 2022 Seeking Alpha
Brickell Biotech press release (BBI): Q4 GAAP EPS of -$0.06 beats by $0.03.Revenue of $0.1M (+233.3% Y/Y) misses by $0.05M.The company reported cash and cash equivalents of…
Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
11:30am, Tuesday, 15'th Mar 2022 GlobeNewswire Inc.
Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral DYRK1A inhibitor, a portfolio of novel STING i
Brickell (BBI) Reports Q4 Loss, Misses Revenue Estimates
09:47am, Tuesday, 15'th Mar 2022
Brickell (BBI) delivered earnings and revenue surprises of 33.33% and 49.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Scheduled For March 15, 2022
08:51am, Tuesday, 15'th Mar 2022 Benzinga
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ: IDYA ) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi Trends (NASDAQ: CTRN ) is projected to report quarterly earnings at $1.12 per share on revenue of $250.54 million. • Precision BioSciences (NASDAQ: DTIL ) is likely to report quarterly loss at $0.47 per share on revenue of $7.75 million. • SPX FLOW (NYSE: FLOW ) is estimated to report quarterly loss at $0.17 per share on revenue of $10.88 million. • Brickell Biotech (NASDAQ: BBI ) is likely to report quarterly loss at $0.08 per share on revenue of $150.00 thousand. • Imara (NASDAQ: IMRA ) is expected to report earnings for its fourth quarter. • Gamida Cell (NASDAQ: GMDA ) is estimated to report earnings for its fourth quarter. • Syros Pharmaceuticals (NASDAQ: SYRS ) is likely to report quarterly loss at $0.47 per share on revenue of $4.80 million. • Global X Guru Index ETF (NYSE: GURU ) is likely to report quarterly loss at $0.
Brickell Biotech Q4 2021 Earnings Preview (NASDAQ:BBI)
04:19pm, Monday, 14'th Mar 2022 Seeking Alpha
Brickell Biotech (NASDAQ:BBI) is scheduled to announce Q4 earnings results on Tuesday, March 15th, before market open.The consensus EPS Estimate is -$0.09 (+40.0% Y/Y) and the…
Glistering Stock: Brickell Biotech, Inc. (NASDAQ:BBI), Antero Resources Corporation (NYSE:AR)
09:35am, Monday, 14'th Mar 2022 Stock Equity
Brickell Biotech, Inc. (NASDAQ:BBI) with the stream of -1.06% also noticed, India Antero Resources Corporation (NYSE:AR) encountered a rapid change of 0.34% in the last hour of Friday’s trading session. … The post Glistering Stock: Brickell Biotech, Inc. (NASDAQ:BBI), Antero Resources Corporation (NYSE:AR) appeared first on Stocks Equity .